Our Pipeline

Our unique therapeutic development pipeline is tailored to address the unmet needs for patient benefits.

Disease Target

Screening

Lead Selection

Preclinical

Clinical Phase 1/2

Type 2 Diabetes

0%

Rett Syndrome

0%

Duchenne Muscular Dystrophy (DMD)

0%

Multiple Sclerosis

0%

Undisclosed Targets

0%

Type 2 Diabetes

Preclincal

0%

Rett Syndrome

Lead Selection

0%

Duchenne Muscular Dystrophy (DMD)

Lead Selection

0%

Multiple Sclerosis

Preclinical

0%

Undisclosed Targets

Lead Selection

0%

Subscribe To Our Newsletter

*By submitting your information, you are granting us permission to email you. You may unsubscribe at any time.

© 2023 All rights Reserved. ProGenis